Year: 2022

Temenos open platform to support leading US Financial Institution’s growth in wealth management Ad hoc announcement pursuant to Art. 53 LR GENEVA, Dec. 13, 2022 (GLOBE NEWSWIRE) — Temenos (SIX: TEMN) today announced that a leading US financial institution is extending its relationship with Temenos to include its international private banking business. The Temenos wealth management platform will support the bank’s strategic transition to a cloud-based core banking system and help drive growth in Europe and the Asia-Pacific (APAC) as it looks to transform its operations and drive efficiencies at scale, while offering first class services and products to its clients. About TemenosTemenos (SIX: TEMN) is the world’s leading open platform for composable banking, creating opportunities for over 1.2 billion people around the world every...

Company announcement no. 49 In company announcement no. 9 2022, Spar Nord announced a share buyback programme of up to DKK 225 million. The share buyback was initiated on 15 June 2022. The purpose of the share buyback is to reduce the bank’s share capital by the shares acquired under the programme, and the programme is executed pursuant to Regulation (EU) No 596/2014 of 16 April 2014 (“Market Abuse Regulation”). In week 49, the following transactions were made under the share buyback programme.  Number of shares Average purchase price Transaction value (DKK)Accumulated from last announcement 2,069,500     175,566,74205 December 2022  9,000  104.02  936,18006 December 2022  9,000  102.69  924,21007 Decembner 2022  9,000  100.15  901,35008 December 2022  9,000  99.01  891,09009 December 2022  9,000  100.00  900,000Total...

Nilorn acquires Bally Labels AG in Switzerland Nilörngruppen AB acquires Bally Labels AG in Switzerland together with two of the employees, Liana Zanin and Ayse Peter, who will own 10 percent each. The acquisition will be effective from December 31, 2022. Martin Bally, the current owner, has been running Bally Label since 1992 and has for the past two years gradually handed over the operation to Liana and Ayse. Bally Label has been a partner company to Nilorn, successfully representing Nilorn in the Swiss market utilizing Nilorn’s services both in Asia and Europe. The purchase price, which not is communicated, is conditional to certain external sales and will be paid in three instalments over three years. As a partner company most of sales are already consolidated in Nilorn’s numbers’ and the acquisition will therefore have limited but...

Supported by new legislation, Arqit’s TradeSecure service is a world first in moving trade finance to quantum safe digital assets LONDON, Dec. 13, 2022 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (“Arqit”), a leader in quantum-safe encryption, has signed a contract with Traxpay GmbH (“Traxpay”), a leader in supply chain financing solutions, to deliver quantum-safe digital finance instruments, enabling supply chain actors to conduct business more efficiently and securely in the new digital trade era. Deployed directly into Traxpay’s supply chain financing platform which has processed over €65bn of supply chain finance assets to date, Arqit’s TradeSecure service uses distributed ledger technology to provide customers with referenceable digital finance instruments (in the form of a Digital Promissory Note or Digital...

Zaandam, the Netherlands, December 13, 2022 – Ahold Delhaize has repurchased 459,000 of its common shares in the period from December 5, 2022 up to and including December 9, 2022. The shares were repurchased at an average price of € 28.22 per share for a total consideration of € 13 million. These repurchases were made as part of the € 1 billion share buyback program announced on November 15, 2021.  The total number of shares repurchased under this program to date is 36,245,640 common shares for a total consideration of € 990.2 million.  Download the share buyback transactions excel sheet for detailed individual transaction information from https://www.aholddelhaize.com/en/investors/share-buyback-programs/2022/  This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation...

TOKYO and CAMBRIDGE, United Kingdom, Dec. 13, 2022 (GLOBE NEWSWIRE) — Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in G protein-coupled receptor (GPCR) focused structure-based drug design (SBDD) and development, announces that it has reached an important R&D milestone under its discovery collaboration with AbbVie, the global biopharmaceutical company, focused on inflammatory and autoimmune diseases. The achievement triggers a payment of US$10 million to Sosei Heptares. Sosei Heptares and AbbVie entered into this discovery collaboration and option-to-license agreement in 2020 to discover, develop and commercialize novel small molecule medicines that modulate GPCR targets of interest to AbbVie. Under the terms of the agreement, Sosei Heptares is eligible to receive up to US$32 million in upfront and...

SAMPO PLC                 STOCK EXCHANGE RELEASE         13/12/2022 at 08:30 am Sampo plc’s share buybacks 12/12/2022 On 12/12/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  15,724 48.82 AQEU  34,191 48.76 CEUX  16,611 48.80 TQEX  111,678 48.79 XHELTOTAL 178,204 48.79  *rounded to two decimals                 On 9 June 2022, Sampo announced a share buyback programme of up to a maximum of EUR 1 billion in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 10 June 2022, is based...

Balixafortide shown to have synergistic or additive effect with conventional or targeted therapies across all tested B-cell lymphomasALLSCHWIL, Switzerland, Dec. 13, 2022 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced results from an in vitro study evaluating the effects of combining Spexis’ potent CXCR4 inhibitor balixafortide (BLX) with several conventional or targeted therapies on the market in B-cell lymphoma models. The research was conducted under the leadership of Prof. Francesco Bertoni at the renowned Institute of Oncology Research in Bellinzona, Switzerland.   The study results demonstrated that the addition of either BLX or another CXCR4 inhibitor from the Spexis macrocycles platform, SPX5551, to conventional or targeted therapies,...

In november, AS LHV Group generated a consolidated net profit of EUR 8.1 million. AS LHV Pank generated EUR 10.0 million in net profit, of which EUR 1.9 million was from servicing clients related to the United Kingdom branch. In November, AS LHV Varahaldus earned EUR 259,000 in net profit. AS LHV Kindlustus generated a net loss of EUR 127,000 and LHV UK Limited generated a net loss of EUR 1.8 million. LHV’s consolidated loan portfolio increased by EUR 28 million over the month. Of this, the increase in retail loans amounted to EUR 15 million, and corporate loans increased by around EUR 13 million. Consolidated deposits decreased by EUR 21 million in November, while deposits of financial intermediaries decreased by EUR 37 million. The volume of funds managed by LHV increased by EUR 42 million over the month. In November, 2.6 million payments...